nodes	percent_of_prediction	percent_of_DWPC	metapath
Cinchocaine—CALM1—type 2 diabetes mellitus	0.666	1	CbGaD
Cinchocaine—BCHE—Ramipril—type 2 diabetes mellitus	0.0969	1	CbGbCtD
Cinchocaine—CALM1—sympathetic nervous system—type 2 diabetes mellitus	0.00659	0.0937	CbGeAlD
Cinchocaine—SCN10A—peripheral nervous system—type 2 diabetes mellitus	0.0052	0.074	CbGeAlD
Cinchocaine—CALM1—autonomic nervous system—type 2 diabetes mellitus	0.00443	0.063	CbGeAlD
Cinchocaine—SCN10A—nerve—type 2 diabetes mellitus	0.00406	0.0577	CbGeAlD
Cinchocaine—CALM2—peripheral nervous system—type 2 diabetes mellitus	0.00321	0.0457	CbGeAlD
Cinchocaine—CALM1—peripheral nervous system—type 2 diabetes mellitus	0.0032	0.0455	CbGeAlD
Cinchocaine—CALM2—artery—type 2 diabetes mellitus	0.00252	0.0359	CbGeAlD
Cinchocaine—CALM1—artery—type 2 diabetes mellitus	0.00251	0.0357	CbGeAlD
Cinchocaine—CALM2—nerve—type 2 diabetes mellitus	0.0025	0.0356	CbGeAlD
Cinchocaine—CALM1—nerve—type 2 diabetes mellitus	0.00249	0.0354	CbGeAlD
Cinchocaine—CALM2—endothelium—type 2 diabetes mellitus	0.00213	0.0303	CbGeAlD
Cinchocaine—CALM1—endothelium—type 2 diabetes mellitus	0.00212	0.0302	CbGeAlD
Cinchocaine—SCN10A—nephron tubule—type 2 diabetes mellitus	0.00158	0.0225	CbGeAlD
Cinchocaine—CALM3—islet of Langerhans—type 2 diabetes mellitus	0.00154	0.022	CbGeAlD
Cinchocaine—CALM3—retina—type 2 diabetes mellitus	0.00132	0.0188	CbGeAlD
Cinchocaine—SCN5A—cardiovascular system—type 2 diabetes mellitus	0.00129	0.0184	CbGeAlD
Cinchocaine—CALM3—nephron tubule—type 2 diabetes mellitus	0.00124	0.0177	CbGeAlD
Cinchocaine—CALM2—islet of Langerhans—type 2 diabetes mellitus	0.00121	0.0172	CbGeAlD
Cinchocaine—CALM1—islet of Langerhans—type 2 diabetes mellitus	0.00121	0.0172	CbGeAlD
Cinchocaine—CALM3—pancreas—type 2 diabetes mellitus	0.00109	0.0154	CbGeAlD
Cinchocaine—CALM3—cortex of kidney—type 2 diabetes mellitus	0.00106	0.0151	CbGeAlD
Cinchocaine—CALM2—retina—type 2 diabetes mellitus	0.00104	0.0147	CbGeAlD
Cinchocaine—CALM1—retina—type 2 diabetes mellitus	0.00103	0.0147	CbGeAlD
Cinchocaine—Procainamide—DNMT1—type 2 diabetes mellitus	0.001	0.339	CrCbGaD
Cinchocaine—CALM3—adipose tissue—type 2 diabetes mellitus	0.000985	0.014	CbGeAlD
Cinchocaine—CALM2—nephron tubule—type 2 diabetes mellitus	0.000976	0.0139	CbGeAlD
Cinchocaine—CALM1—nephron tubule—type 2 diabetes mellitus	0.000972	0.0138	CbGeAlD
Cinchocaine—CALM2—cardiovascular system—type 2 diabetes mellitus	0.000877	0.0125	CbGeAlD
Cinchocaine—CALM1—cardiovascular system—type 2 diabetes mellitus	0.000873	0.0124	CbGeAlD
Cinchocaine—CALM2—kidney—type 2 diabetes mellitus	0.000858	0.0122	CbGeAlD
Cinchocaine—CALM1—kidney—type 2 diabetes mellitus	0.000854	0.0121	CbGeAlD
Cinchocaine—CALM2—pancreas—type 2 diabetes mellitus	0.000852	0.0121	CbGeAlD
Cinchocaine—CALM1—pancreas—type 2 diabetes mellitus	0.000848	0.0121	CbGeAlD
Cinchocaine—CALM2—cortex of kidney—type 2 diabetes mellitus	0.000835	0.0119	CbGeAlD
Cinchocaine—CALM1—cortex of kidney—type 2 diabetes mellitus	0.000832	0.0118	CbGeAlD
Cinchocaine—BCHE—nephron tubule—type 2 diabetes mellitus	0.000814	0.0116	CbGeAlD
Cinchocaine—CALM2—adipose tissue—type 2 diabetes mellitus	0.000773	0.011	CbGeAlD
Cinchocaine—CALM1—adipose tissue—type 2 diabetes mellitus	0.00077	0.0109	CbGeAlD
Cinchocaine—BCHE—cardiovascular system—type 2 diabetes mellitus	0.000731	0.0104	CbGeAlD
Cinchocaine—CALM3—liver—type 2 diabetes mellitus	0.00069	0.00982	CbGeAlD
Cinchocaine—Chloroquine—TNF—type 2 diabetes mellitus	0.000653	0.221	CrCbGaD
Cinchocaine—BCHE—adipose tissue—type 2 diabetes mellitus	0.000645	0.00917	CbGeAlD
Cinchocaine—CALM2—liver—type 2 diabetes mellitus	0.000542	0.00771	CbGeAlD
Cinchocaine—CALM1—liver—type 2 diabetes mellitus	0.00054	0.00768	CbGeAlD
Cinchocaine—BCHE—liver—type 2 diabetes mellitus	0.000452	0.00643	CbGeAlD
Cinchocaine—Amiodarone—CYP1A2—type 2 diabetes mellitus	0.000374	0.127	CrCbGaD
Cinchocaine—Quinacrine—CYP3A4—type 2 diabetes mellitus	0.000357	0.121	CrCbGaD
Cinchocaine—Chloroquine—CYP3A4—type 2 diabetes mellitus	0.000317	0.107	CrCbGaD
Cinchocaine—Amiodarone—CYP3A4—type 2 diabetes mellitus	0.000248	0.0839	CrCbGaD
Cinchocaine—CALM1—Disease—NOS2—type 2 diabetes mellitus	6.25e-06	3.8e-05	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—IGF2—type 2 diabetes mellitus	6.25e-06	3.8e-05	CbGpPWpGaD
Cinchocaine—CALM3—Metabolism—MTHFR—type 2 diabetes mellitus	6.23e-06	3.79e-05	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	6.22e-06	3.78e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	6.21e-06	3.77e-05	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	6.21e-06	3.77e-05	CbGpPWpGaD
Cinchocaine—CALM3—Immune System—AKT2—type 2 diabetes mellitus	6.2e-06	3.77e-05	CbGpPWpGaD
Cinchocaine—CALM3—Disease—IRS1—type 2 diabetes mellitus	6.18e-06	3.76e-05	CbGpPWpGaD
Cinchocaine—BCHE—Metabolism—PTGS2—type 2 diabetes mellitus	6.18e-06	3.75e-05	CbGpPWpGaD
Cinchocaine—CALM3—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	6.16e-06	3.74e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—GNB3—type 2 diabetes mellitus	6.15e-06	3.74e-05	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—GNB3—type 2 diabetes mellitus	6.15e-06	3.74e-05	CbGpPWpGaD
Cinchocaine—CALM3—Metabolism—PPARA—type 2 diabetes mellitus	6.12e-06	3.72e-05	CbGpPWpGaD
Cinchocaine—CALM2—Immune System—CASP8—type 2 diabetes mellitus	6.1e-06	3.71e-05	CbGpPWpGaD
Cinchocaine—CALM1—Immune System—CASP8—type 2 diabetes mellitus	6.1e-06	3.71e-05	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—MMP3—type 2 diabetes mellitus	6.07e-06	3.69e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—MMP3—type 2 diabetes mellitus	6.07e-06	3.69e-05	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—AVP—type 2 diabetes mellitus	6.07e-06	3.69e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—AVP—type 2 diabetes mellitus	6.07e-06	3.69e-05	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—APOB—type 2 diabetes mellitus	6.06e-06	3.69e-05	CbGpPWpGaD
Cinchocaine—CALM1—Innate Immune System—EGFR—type 2 diabetes mellitus	6.06e-06	3.68e-05	CbGpPWpGaD
Cinchocaine—CALM2—Innate Immune System—EGFR—type 2 diabetes mellitus	6.06e-06	3.68e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—IGF2—type 2 diabetes mellitus	6.04e-06	3.67e-05	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—IGF2—type 2 diabetes mellitus	6.04e-06	3.67e-05	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—IGF1R—type 2 diabetes mellitus	6.04e-06	3.67e-05	CbGpPWpGaD
Cinchocaine—CALM1—Metabolism—MTHFR—type 2 diabetes mellitus	6.03e-06	3.67e-05	CbGpPWpGaD
Cinchocaine—CALM2—Metabolism—MTHFR—type 2 diabetes mellitus	6.03e-06	3.67e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	6.02e-06	3.66e-05	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	6.02e-06	3.66e-05	CbGpPWpGaD
Cinchocaine—CALM3—Adaptive Immune System—EGFR—type 2 diabetes mellitus	6.01e-06	3.65e-05	CbGpPWpGaD
Cinchocaine—CALM2—Immune System—AKT2—type 2 diabetes mellitus	6e-06	3.64e-05	CbGpPWpGaD
Cinchocaine—CALM1—Immune System—AKT2—type 2 diabetes mellitus	6e-06	3.64e-05	CbGpPWpGaD
Cinchocaine—CALM2—Disease—IRS1—type 2 diabetes mellitus	5.98e-06	3.63e-05	CbGpPWpGaD
Cinchocaine—CALM1—Disease—IRS1—type 2 diabetes mellitus	5.98e-06	3.63e-05	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—EDN1—type 2 diabetes mellitus	5.97e-06	3.63e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	5.95e-06	3.62e-05	CbGpPWpGaD
Cinchocaine—CALM1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	5.95e-06	3.62e-05	CbGpPWpGaD
Cinchocaine—CALM3—Metabolism—AGT—type 2 diabetes mellitus	5.92e-06	3.6e-05	CbGpPWpGaD
Cinchocaine—CALM3—Disease—INS—type 2 diabetes mellitus	5.92e-06	3.6e-05	CbGpPWpGaD
Cinchocaine—CALM1—Metabolism—PPARA—type 2 diabetes mellitus	5.92e-06	3.6e-05	CbGpPWpGaD
Cinchocaine—CALM2—Metabolism—PPARA—type 2 diabetes mellitus	5.92e-06	3.6e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—APOB—type 2 diabetes mellitus	5.87e-06	3.56e-05	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—APOB—type 2 diabetes mellitus	5.87e-06	3.56e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—IGF1R—type 2 diabetes mellitus	5.84e-06	3.55e-05	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	5.84e-06	3.55e-05	CbGpPWpGaD
Cinchocaine—CALM3—Metabolism—CALM1—type 2 diabetes mellitus	5.82e-06	3.54e-05	CbGpPWpGaD
Cinchocaine—CALM2—Adaptive Immune System—EGFR—type 2 diabetes mellitus	5.82e-06	3.53e-05	CbGpPWpGaD
Cinchocaine—CALM1—Adaptive Immune System—EGFR—type 2 diabetes mellitus	5.82e-06	3.53e-05	CbGpPWpGaD
Cinchocaine—CALM3—Metabolism—APOE—type 2 diabetes mellitus	5.8e-06	3.53e-05	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—LPL—type 2 diabetes mellitus	5.79e-06	3.52e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—EDN1—type 2 diabetes mellitus	5.77e-06	3.51e-05	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—EDN1—type 2 diabetes mellitus	5.77e-06	3.51e-05	CbGpPWpGaD
Cinchocaine—CALM3—Metabolism—APOA1—type 2 diabetes mellitus	5.74e-06	3.49e-05	CbGpPWpGaD
Cinchocaine—CALM2—Metabolism—AGT—type 2 diabetes mellitus	5.73e-06	3.48e-05	CbGpPWpGaD
Cinchocaine—CALM1—Metabolism—AGT—type 2 diabetes mellitus	5.73e-06	3.48e-05	CbGpPWpGaD
Cinchocaine—CALM1—Disease—INS—type 2 diabetes mellitus	5.73e-06	3.48e-05	CbGpPWpGaD
Cinchocaine—CALM2—Disease—INS—type 2 diabetes mellitus	5.73e-06	3.48e-05	CbGpPWpGaD
Cinchocaine—CALM3—Disease—AKT2—type 2 diabetes mellitus	5.72e-06	3.48e-05	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—ADCY5—type 2 diabetes mellitus	5.67e-06	3.44e-05	CbGpPWpGaD
Cinchocaine—CALM2—Metabolism—CALM1—type 2 diabetes mellitus	5.63e-06	3.42e-05	CbGpPWpGaD
Cinchocaine—CALM3—Immune System—PIK3R1—type 2 diabetes mellitus	5.62e-06	3.42e-05	CbGpPWpGaD
Cinchocaine—CALM2—Metabolism—APOE—type 2 diabetes mellitus	5.61e-06	3.41e-05	CbGpPWpGaD
Cinchocaine—CALM1—Metabolism—APOE—type 2 diabetes mellitus	5.61e-06	3.41e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—LPL—type 2 diabetes mellitus	5.6e-06	3.4e-05	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—LPL—type 2 diabetes mellitus	5.6e-06	3.4e-05	CbGpPWpGaD
Cinchocaine—CALM2—Metabolism—APOA1—type 2 diabetes mellitus	5.55e-06	3.37e-05	CbGpPWpGaD
Cinchocaine—CALM1—Metabolism—APOA1—type 2 diabetes mellitus	5.55e-06	3.37e-05	CbGpPWpGaD
Cinchocaine—CALM1—Disease—AKT2—type 2 diabetes mellitus	5.54e-06	3.36e-05	CbGpPWpGaD
Cinchocaine—CALM2—Disease—AKT2—type 2 diabetes mellitus	5.54e-06	3.36e-05	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	5.48e-06	3.33e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	5.48e-06	3.33e-05	CbGpPWpGaD
Cinchocaine—CALM2—Immune System—PIK3R1—type 2 diabetes mellitus	5.44e-06	3.31e-05	CbGpPWpGaD
Cinchocaine—CALM1—Immune System—PIK3R1—type 2 diabetes mellitus	5.44e-06	3.31e-05	CbGpPWpGaD
Cinchocaine—CALM3—Disease—SERPINE1—type 2 diabetes mellitus	5.44e-06	3.31e-05	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	5.43e-06	3.3e-05	CbGpPWpGaD
Cinchocaine—CALM3—Immune System—BCL2—type 2 diabetes mellitus	5.41e-06	3.29e-05	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—CCR5—type 2 diabetes mellitus	5.33e-06	3.24e-05	CbGpPWpGaD
Cinchocaine—CALM3—Immune System—RELA—type 2 diabetes mellitus	5.29e-06	3.22e-05	CbGpPWpGaD
Cinchocaine—CALM2—Disease—SERPINE1—type 2 diabetes mellitus	5.26e-06	3.2e-05	CbGpPWpGaD
Cinchocaine—CALM1—Disease—SERPINE1—type 2 diabetes mellitus	5.26e-06	3.2e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	5.26e-06	3.19e-05	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	5.26e-06	3.19e-05	CbGpPWpGaD
Cinchocaine—CALM2—Immune System—BCL2—type 2 diabetes mellitus	5.24e-06	3.18e-05	CbGpPWpGaD
Cinchocaine—CALM1—Immune System—BCL2—type 2 diabetes mellitus	5.24e-06	3.18e-05	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—C3—type 2 diabetes mellitus	5.21e-06	3.17e-05	CbGpPWpGaD
Cinchocaine—CALM3—Disease—PIK3R1—type 2 diabetes mellitus	5.19e-06	3.16e-05	CbGpPWpGaD
Cinchocaine—CALM3—Disease—NOS3—type 2 diabetes mellitus	5.19e-06	3.16e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—CCR5—type 2 diabetes mellitus	5.16e-06	3.14e-05	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—CCR5—type 2 diabetes mellitus	5.16e-06	3.14e-05	CbGpPWpGaD
Cinchocaine—CALM1—Immune System—RELA—type 2 diabetes mellitus	5.12e-06	3.11e-05	CbGpPWpGaD
Cinchocaine—CALM2—Immune System—RELA—type 2 diabetes mellitus	5.12e-06	3.11e-05	CbGpPWpGaD
Cinchocaine—CALM3—Metabolism—PPARG—type 2 diabetes mellitus	5.06e-06	3.07e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—C3—type 2 diabetes mellitus	5.04e-06	3.06e-05	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—C3—type 2 diabetes mellitus	5.04e-06	3.06e-05	CbGpPWpGaD
Cinchocaine—CALM2—Disease—PIK3R1—type 2 diabetes mellitus	5.02e-06	3.05e-05	CbGpPWpGaD
Cinchocaine—CALM2—Disease—NOS3—type 2 diabetes mellitus	5.02e-06	3.05e-05	CbGpPWpGaD
Cinchocaine—CALM1—Disease—NOS3—type 2 diabetes mellitus	5.02e-06	3.05e-05	CbGpPWpGaD
Cinchocaine—CALM1—Disease—PIK3R1—type 2 diabetes mellitus	5.02e-06	3.05e-05	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—HIF1A—type 2 diabetes mellitus	4.97e-06	3.02e-05	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—IRS2—type 2 diabetes mellitus	4.96e-06	3.01e-05	CbGpPWpGaD
Cinchocaine—CALM3—Metabolism—INS—type 2 diabetes mellitus	4.96e-06	3.01e-05	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—AGT—type 2 diabetes mellitus	4.95e-06	3.01e-05	CbGpPWpGaD
Cinchocaine—CALM3—Hemostasis—AKT1—type 2 diabetes mellitus	4.93e-06	3e-05	CbGpPWpGaD
Cinchocaine—CALM2—Metabolism—PPARG—type 2 diabetes mellitus	4.89e-06	2.97e-05	CbGpPWpGaD
Cinchocaine—CALM1—Metabolism—PPARG—type 2 diabetes mellitus	4.89e-06	2.97e-05	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—CALM1—type 2 diabetes mellitus	4.87e-06	2.96e-05	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—LEP—type 2 diabetes mellitus	4.85e-06	2.95e-05	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—APOE—type 2 diabetes mellitus	4.85e-06	2.95e-05	CbGpPWpGaD
Cinchocaine—CALM3—Innate Immune System—IL6—type 2 diabetes mellitus	4.81e-06	2.92e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	4.81e-06	2.92e-05	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	4.81e-06	2.92e-05	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—APOA1—type 2 diabetes mellitus	4.8e-06	2.92e-05	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—IRS2—type 2 diabetes mellitus	4.8e-06	2.92e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—IRS2—type 2 diabetes mellitus	4.8e-06	2.92e-05	CbGpPWpGaD
Cinchocaine—CALM2—Metabolism—INS—type 2 diabetes mellitus	4.8e-06	2.92e-05	CbGpPWpGaD
Cinchocaine—CALM1—Metabolism—INS—type 2 diabetes mellitus	4.8e-06	2.92e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—AGT—type 2 diabetes mellitus	4.79e-06	2.91e-05	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—AGT—type 2 diabetes mellitus	4.79e-06	2.91e-05	CbGpPWpGaD
Cinchocaine—CALM2—Hemostasis—AKT1—type 2 diabetes mellitus	4.77e-06	2.9e-05	CbGpPWpGaD
Cinchocaine—CALM1—Hemostasis—AKT1—type 2 diabetes mellitus	4.77e-06	2.9e-05	CbGpPWpGaD
Cinchocaine—CALM3—Disease—PTGS2—type 2 diabetes mellitus	4.75e-06	2.89e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—CALM1—type 2 diabetes mellitus	4.71e-06	2.86e-05	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—LEP—type 2 diabetes mellitus	4.69e-06	2.85e-05	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—APOE—type 2 diabetes mellitus	4.69e-06	2.85e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—APOE—type 2 diabetes mellitus	4.69e-06	2.85e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—LEP—type 2 diabetes mellitus	4.69e-06	2.85e-05	CbGpPWpGaD
Cinchocaine—CALM2—Innate Immune System—IL6—type 2 diabetes mellitus	4.65e-06	2.83e-05	CbGpPWpGaD
Cinchocaine—CALM1—Innate Immune System—IL6—type 2 diabetes mellitus	4.65e-06	2.83e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—APOA1—type 2 diabetes mellitus	4.64e-06	2.82e-05	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—APOA1—type 2 diabetes mellitus	4.64e-06	2.82e-05	CbGpPWpGaD
Cinchocaine—CALM2—Disease—PTGS2—type 2 diabetes mellitus	4.59e-06	2.79e-05	CbGpPWpGaD
Cinchocaine—CALM1—Disease—PTGS2—type 2 diabetes mellitus	4.59e-06	2.79e-05	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—PRKCB—type 2 diabetes mellitus	4.58e-06	2.78e-05	CbGpPWpGaD
Cinchocaine—CALM3—Metabolism—ALB—type 2 diabetes mellitus	4.55e-06	2.76e-05	CbGpPWpGaD
Cinchocaine—CALM3—Immune System—NFKB1—type 2 diabetes mellitus	4.46e-06	2.71e-05	CbGpPWpGaD
Cinchocaine—CALM3—Innate Immune System—AKT1—type 2 diabetes mellitus	4.44e-06	2.7e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	4.43e-06	2.69e-05	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	4.43e-06	2.69e-05	CbGpPWpGaD
Cinchocaine—CALM2—Metabolism—ALB—type 2 diabetes mellitus	4.4e-06	2.67e-05	CbGpPWpGaD
Cinchocaine—CALM1—Metabolism—ALB—type 2 diabetes mellitus	4.4e-06	2.67e-05	CbGpPWpGaD
Cinchocaine—CALM3—Metabolism—PIK3R1—type 2 diabetes mellitus	4.35e-06	2.64e-05	CbGpPWpGaD
Cinchocaine—CALM3—Metabolism—NOS3—type 2 diabetes mellitus	4.35e-06	2.64e-05	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—IRS1—type 2 diabetes mellitus	4.33e-06	2.63e-05	CbGpPWpGaD
Cinchocaine—CALM2—Immune System—NFKB1—type 2 diabetes mellitus	4.32e-06	2.62e-05	CbGpPWpGaD
Cinchocaine—CALM1—Immune System—NFKB1—type 2 diabetes mellitus	4.32e-06	2.62e-05	CbGpPWpGaD
Cinchocaine—CALM2—Innate Immune System—AKT1—type 2 diabetes mellitus	4.29e-06	2.61e-05	CbGpPWpGaD
Cinchocaine—CALM1—Innate Immune System—AKT1—type 2 diabetes mellitus	4.29e-06	2.61e-05	CbGpPWpGaD
Cinchocaine—CALM3—Adaptive Immune System—AKT1—type 2 diabetes mellitus	4.26e-06	2.59e-05	CbGpPWpGaD
Cinchocaine—CALM1—Metabolism—PIK3R1—type 2 diabetes mellitus	4.21e-06	2.56e-05	CbGpPWpGaD
Cinchocaine—CALM2—Metabolism—NOS3—type 2 diabetes mellitus	4.21e-06	2.56e-05	CbGpPWpGaD
Cinchocaine—CALM1—Metabolism—NOS3—type 2 diabetes mellitus	4.21e-06	2.56e-05	CbGpPWpGaD
Cinchocaine—CALM2—Metabolism—PIK3R1—type 2 diabetes mellitus	4.21e-06	2.56e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—IRS1—type 2 diabetes mellitus	4.19e-06	2.55e-05	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—IRS1—type 2 diabetes mellitus	4.19e-06	2.55e-05	CbGpPWpGaD
Cinchocaine—CALM3—Immune System—SRC—type 2 diabetes mellitus	4.16e-06	2.53e-05	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—INS—type 2 diabetes mellitus	4.15e-06	2.52e-05	CbGpPWpGaD
Cinchocaine—CALM1—Adaptive Immune System—AKT1—type 2 diabetes mellitus	4.12e-06	2.51e-05	CbGpPWpGaD
Cinchocaine—CALM2—Adaptive Immune System—AKT1—type 2 diabetes mellitus	4.12e-06	2.51e-05	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—CCL2—type 2 diabetes mellitus	4.08e-06	2.48e-05	CbGpPWpGaD
Cinchocaine—CALM1—Immune System—SRC—type 2 diabetes mellitus	4.02e-06	2.45e-05	CbGpPWpGaD
Cinchocaine—CALM2—Immune System—SRC—type 2 diabetes mellitus	4.02e-06	2.45e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—INS—type 2 diabetes mellitus	4.01e-06	2.44e-05	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—INS—type 2 diabetes mellitus	4.01e-06	2.44e-05	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—IGF1—type 2 diabetes mellitus	4.01e-06	2.44e-05	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—AKT2—type 2 diabetes mellitus	4.01e-06	2.44e-05	CbGpPWpGaD
Cinchocaine—CALM3—Signaling by GPCR—EGFR—type 2 diabetes mellitus	3.99e-06	2.43e-05	CbGpPWpGaD
Cinchocaine—CALM3—Metabolism—PTGS2—type 2 diabetes mellitus	3.98e-06	2.42e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—CCL2—type 2 diabetes mellitus	3.95e-06	2.4e-05	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—CCL2—type 2 diabetes mellitus	3.95e-06	2.4e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—IGF1—type 2 diabetes mellitus	3.88e-06	2.36e-05	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—IGF1—type 2 diabetes mellitus	3.88e-06	2.36e-05	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—AKT2—type 2 diabetes mellitus	3.88e-06	2.36e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—AKT2—type 2 diabetes mellitus	3.88e-06	2.36e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	3.86e-06	2.35e-05	CbGpPWpGaD
Cinchocaine—CALM1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	3.86e-06	2.35e-05	CbGpPWpGaD
Cinchocaine—CALM2—Metabolism—PTGS2—type 2 diabetes mellitus	3.85e-06	2.34e-05	CbGpPWpGaD
Cinchocaine—CALM1—Metabolism—PTGS2—type 2 diabetes mellitus	3.85e-06	2.34e-05	CbGpPWpGaD
Cinchocaine—CALM3—Disease—SRC—type 2 diabetes mellitus	3.84e-06	2.33e-05	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	3.81e-06	2.31e-05	CbGpPWpGaD
Cinchocaine—CALM1—Disease—SRC—type 2 diabetes mellitus	3.72e-06	2.26e-05	CbGpPWpGaD
Cinchocaine—CALM2—Disease—SRC—type 2 diabetes mellitus	3.72e-06	2.26e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	3.68e-06	2.24e-05	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	3.68e-06	2.24e-05	CbGpPWpGaD
Cinchocaine—CALM3—Immune System—EGFR—type 2 diabetes mellitus	3.65e-06	2.22e-05	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	3.64e-06	2.21e-05	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—NOS3—type 2 diabetes mellitus	3.64e-06	2.21e-05	CbGpPWpGaD
Cinchocaine—CALM2—Immune System—EGFR—type 2 diabetes mellitus	3.53e-06	2.14e-05	CbGpPWpGaD
Cinchocaine—CALM1—Immune System—EGFR—type 2 diabetes mellitus	3.53e-06	2.14e-05	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—NOS3—type 2 diabetes mellitus	3.52e-06	2.14e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	3.52e-06	2.14e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—NOS3—type 2 diabetes mellitus	3.52e-06	2.14e-05	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	3.52e-06	2.14e-05	CbGpPWpGaD
Cinchocaine—CALM3—Disease—TGFB1—type 2 diabetes mellitus	3.43e-06	2.09e-05	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—RELA—type 2 diabetes mellitus	3.42e-06	2.08e-05	CbGpPWpGaD
Cinchocaine—CALM3—Disease—EGFR—type 2 diabetes mellitus	3.37e-06	2.05e-05	CbGpPWpGaD
Cinchocaine—CALM2—Disease—TGFB1—type 2 diabetes mellitus	3.32e-06	2.02e-05	CbGpPWpGaD
Cinchocaine—CALM1—Disease—TGFB1—type 2 diabetes mellitus	3.32e-06	2.02e-05	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—RELA—type 2 diabetes mellitus	3.31e-06	2.01e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—RELA—type 2 diabetes mellitus	3.31e-06	2.01e-05	CbGpPWpGaD
Cinchocaine—CALM2—Disease—EGFR—type 2 diabetes mellitus	3.26e-06	1.98e-05	CbGpPWpGaD
Cinchocaine—CALM1—Disease—EGFR—type 2 diabetes mellitus	3.26e-06	1.98e-05	CbGpPWpGaD
Cinchocaine—BCHE—Metabolism—AKT1—type 2 diabetes mellitus	3.1e-06	1.89e-05	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.09e-06	1.88e-05	CbGpPWpGaD
Cinchocaine—CALM3—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.07e-06	1.86e-05	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.99e-06	1.81e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.99e-06	1.81e-05	CbGpPWpGaD
Cinchocaine—CALM1—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.97e-06	1.8e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.97e-06	1.8e-05	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.92e-06	1.77e-05	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.89e-06	1.75e-05	CbGpPWpGaD
Cinchocaine—CALM3—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.83e-06	1.72e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.82e-06	1.72e-05	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.82e-06	1.72e-05	CbGpPWpGaD
Cinchocaine—CALM3—Immune System—IL6—type 2 diabetes mellitus	2.8e-06	1.7e-05	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.79e-06	1.7e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.79e-06	1.7e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.74e-06	1.66e-05	CbGpPWpGaD
Cinchocaine—CALM1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.74e-06	1.66e-05	CbGpPWpGaD
Cinchocaine—CALM1—Immune System—IL6—type 2 diabetes mellitus	2.71e-06	1.65e-05	CbGpPWpGaD
Cinchocaine—CALM2—Immune System—IL6—type 2 diabetes mellitus	2.71e-06	1.65e-05	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—SRC—type 2 diabetes mellitus	2.69e-06	1.63e-05	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.62e-06	1.59e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—SRC—type 2 diabetes mellitus	2.6e-06	1.58e-05	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—SRC—type 2 diabetes mellitus	2.6e-06	1.58e-05	CbGpPWpGaD
Cinchocaine—CALM3—Disease—IL6—type 2 diabetes mellitus	2.59e-06	1.57e-05	CbGpPWpGaD
Cinchocaine—CALM3—Immune System—AKT1—type 2 diabetes mellitus	2.59e-06	1.57e-05	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.53e-06	1.54e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.53e-06	1.54e-05	CbGpPWpGaD
Cinchocaine—CALM1—Disease—IL6—type 2 diabetes mellitus	2.5e-06	1.52e-05	CbGpPWpGaD
Cinchocaine—CALM2—Disease—IL6—type 2 diabetes mellitus	2.5e-06	1.52e-05	CbGpPWpGaD
Cinchocaine—CALM2—Immune System—AKT1—type 2 diabetes mellitus	2.5e-06	1.52e-05	CbGpPWpGaD
Cinchocaine—CALM1—Immune System—AKT1—type 2 diabetes mellitus	2.5e-06	1.52e-05	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.4e-06	1.46e-05	CbGpPWpGaD
Cinchocaine—CALM3—Disease—AKT1—type 2 diabetes mellitus	2.39e-06	1.45e-05	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.36e-06	1.43e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.33e-06	1.41e-05	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.33e-06	1.41e-05	CbGpPWpGaD
Cinchocaine—CALM1—Disease—AKT1—type 2 diabetes mellitus	2.31e-06	1.4e-05	CbGpPWpGaD
Cinchocaine—CALM2—Disease—AKT1—type 2 diabetes mellitus	2.31e-06	1.4e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.28e-06	1.39e-05	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.28e-06	1.39e-05	CbGpPWpGaD
Cinchocaine—CALM3—Metabolism—AKT1—type 2 diabetes mellitus	2e-06	1.21e-05	CbGpPWpGaD
Cinchocaine—CALM2—Metabolism—AKT1—type 2 diabetes mellitus	1.93e-06	1.18e-05	CbGpPWpGaD
Cinchocaine—CALM1—Metabolism—AKT1—type 2 diabetes mellitus	1.93e-06	1.18e-05	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—IL6—type 2 diabetes mellitus	1.81e-06	1.1e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—IL6—type 2 diabetes mellitus	1.75e-06	1.07e-05	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—IL6—type 2 diabetes mellitus	1.75e-06	1.07e-05	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.67e-06	1.02e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.62e-06	9.83e-06	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.62e-06	9.83e-06	CbGpPWpGaD
